BRIEF-Standard BioTools Enters Strategic Sale Of SomaLogic To Illumina

Reuters
23 Jun
BRIEF-Standard BioTools Enters Strategic Sale Of SomaLogic To <a href="https://laohu8.com/S/ILMN">Illumina</a>

June 23 (Reuters) -

  • STANDARD BIOTOOLS- DEAL VALUED AT UP TO $425 MILLION WITH $350 MILLION UPFRONT

  • STANDARD BIOTOOLS ENTERS NEXT PHASE OF TRANSFORMATION WITH STRATEGIC SALE OF SOMALOGIC TO ILLUMINA

Source text: ID:nGNX14Dxx

Further company coverage: ILMN.O

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10